“The supply chain simply cannot manage the cost, complexity or demands of the proposed full track and trace model. It’s just not clear to me, or anyone I suspect, exactly what the problem the model is trying to solve. Any issues that relate ot a relatively small number of medicines does not require a complex unworkable solution that will have significant impact on the more than two million products distributed to community pharmacy every working day.”
Read the full article here: ‘Does anyone know? If they do, can they tell me?’ – BioPharmaDispatch
